Showing results (431-440 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
Neuro-Oncology Advances|January 7, 2026
Unsupervised learning of metabolic fingerprints from 3D magnetic resonance spectroscopic imaging enables glioma subtype classificationGulnur S Ungan, Paul J Weiser, Jorg Dietrich, et al.
Neuro-Oncology Advances|December 31, 2025
DIAPH3 is upregulated in high-grade gliomas and linked to chromosomal instabilityCaren Jabbour, Mathilde Beka, Philippe Gailly, et al.
Neuro-Oncology Advances|January 7, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?Christoph Oster, Pia Reineck, Teresa Schmidt, et al.
Neuro-Oncology Advances|April 14, 2025
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomasStuart A Grossman, Carlos G Romo, Xiaobu Ye, et al.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
Neuro-Oncology Advances|May 12, 2025
Integrated early palliative care for patients with newly diagnosed glioblastoma: The GLIOSUPPORT feasibility studyMichel Fabbro, Muriel Thomaso, Amélie Darlix, et al.
Neuro-Oncology Advances|May 12, 2025
What single-cell RNA sequencing taught us about MGMT expression in glioblastomaIyad Alnahhas, Mehak Majid Khan, Wenyin Shi
Neuro-Oncology Advances|September 22, 2025
Self-assembling polypeptide-drug conjugates as innovative therapeutic candidates for glioblastoma treatment by enhancing intracranial residence timeYunjeong Gwon, Jung Eun Kim, Wooram Jung, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
Pageof 134